Cambridge BioMedical Cluster
With a 25-year track record in biomedical research and development spanning the discovery of new medicines (including the blockbuster drug Humira), innovative medical technologies and research into novel cell-based therapies, today the Cambridge cluster is increasingly focused on translational research.
Major areas of expertise are cancer, neurosciences, metabolic disorders and inflammation and infection. Clinical and non-clinical scientists routinely collaborate on the discovery of personalized medicines as well as undertaking experimental clinical trials at the world-class facilities at Cambridge University Hospitals.
Building on the legacy of the “Cambridge Phenomenon” – the transformation of Cambridge into one of the top technology clusters in the world – the new generation of companies are exploiting opportunities at the intersection of the life, physical and engineering sciences.
Phone: +44 1223 421555